MEDINDIA
English
हिन्दी
Español
français
中文
HYDERABAD, India, Dec. 4, 2025
HYDERABAD, India, Dec. 4, 2025 /PRNewswire/ -- According to a recent report by Mordor Intelligence, the generic injectables market size is valued at USD 131.68 billion in 2025 and is projected to surpass USD 251.03 billion in 2030, at a 13.78% CAGR through the forecast period 2025-2030, supported by growing demand for affordable biologic and small-molecule therapies. As healthcare systems worldwide continue to manage escalating treatment costs, generic injectables have emerged as a cornerstone in ensuring accessibility and affordability of life-saving medications.
The generic injectables market benefits from a strong pipeline of patent expirations and increasing investments in sterile manufacturing. The global shift toward hospital-based care and the rising prevalence of chronic and infectious diseases further reinforce the adoption of injectable generics. Biopharmaceutical firms are expanding their generic injectable portfolios, focusing on oncology, cardiovascular, and anti-infective segments, where injectables dominate clinical use.
Market Growth Drivers
Segmentation Insights
The generic injectables market is segmented by molecule type, product type, route of administration, therapeutic area, distribution channel, and geography.
By Product Type
By Molecule Type
By Therapeutic Area
By Route of Administration
By Distribution Channel
To know more about the segments driving the market growth, visit - https://www.mordorintelligence.com/industry-reports/generic-injectables-market?utm_source=prnewswire
Regional Market Dynamics
North America leads the global generic injectables market, backed by strong FDA approvals and established manufacturing infrastructure. Europe follows with expanded biosimilar adoption and centralized procurement programs. Asia-Pacific is emerging as a high-growth region, driven by government incentives, rising domestic production capacity, and increasing healthcare expenditure.
North America
Europe
Asia-Pacific
Middle East & Africa
South America
Competitive Environment
The market remains moderately consolidated, with global and regional players focusing on cost leadership, sterile manufacturing expansion, and portfolio diversification. Strategic alliances and partnerships for biosimilar injectables are increasingly shaping the competitive environment.
Prominent companies operating in the generic injectables market include:
Industry Related Reports
Injectable Anti-diabetic Drugs Market: The injectable anti-diabetic drugs market report is segmented by drug class (insulin [basal/long-acting], GLP-1 receptor agonists), diabetes type (type-1 diabetes, type-2 diabetes), distribution channel (hospital pharmacies, retail pharmacies, online pharmacies), age group (adults, geriatric, pediatric), and geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America).
Muscle Relaxant Drugs Market: The muscle relaxant drugs market report is segmented by drug type (facial aesthetic relaxants, skeletal muscle relaxants), formulation (oral, injectable, transdermal/topical), distribution channel (hospital pharmacy, retail pharmacy, online pharmacy), and geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America).
Injection Pen Market: The Injection pen market report is segmented by product type (disposable, reusable, smart/connected), indication (diabetes, autoimmune diseases, growth hormone deficiency, oncology supportive care, osteoporosis, other indications), distribution channel (hospital pharmacies), and geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America).
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries, please contact: [email protected]://www.mordorintelligence.com/contact-us
Logo: https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/generic-injectables-market-dominated-by-hospital-pharmacies-with-61-23-share-as-online-pharmacies-surge-at-18-06-cagr-through-2030--reports-mordor-intelligence-302632868.html
SOURCE Mordor Intelligence Private Limited
